Maze Therapeutics 株価情報 (NASDAQ: MAZE)

最新ニュース Maze Therapeutics (NASDAQ:MAZE) 株価情報

Maze Therapeutics

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Five,Below,Now,Open,-,Closeup,Of,Sign,On,Building

AGMH

AKBA

BHIL

DEVS

EFXT

FIVE

IOBT

MAZE

MHUA

OPTN

RVSB

VRPX

ZCAR

米国の小売業者ファイブ・ビロウ(Five Below）の株は、市場予想を上回る四半期決算を発表し、第1四半期の見通し予想を上回ることを受け、市場取引開始前の取引で株価が急上昇した。

なぜ、ファイブ・ビロウの株価が12%上昇しているのか；プレマーケットで変動している20銘柄

Maze Therapeutics Inc

News

General

SBET

SharpLink Gaming Files For Mixed Shelf Offering; Size Not Disclosed

CELU

Celularity Receives Nasdaq Letter Regarding Form 10-Q

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) has outperformed the market over the past 15 years by 5.91% on an annualized basis producing an average annual return of 18.07%. Currently, Salesforce has a market capitalization of $253.42 billion. 
Buying $1000 In CRM: If an investor had bought $1000 of CRM stock 15 years ago, it would be worth $11,841.59 today based on a price of $265.08 for CRM at the time of writing.
<h3>Salesforce's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748640629_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

<ul>
<li>Updated interim results with an additional ~16 weeks of follow-up on nine patients in Cohort 1 (2.5 mCi) and Cohort 2 (5.0 mCi) and initial safety findings in an additional 33 patients treated in Cohort 2 from the ongoing Phase 1/2a study were presented</li>
<li>[212Pb]VMT-α-NET continued to have a favorable safety profile, with no dose-limiting toxicities and no discontinuations due to adverse events observed among a total of 42 patients who received at least one treatment</li>
<li>Four of seven patients in Cohort 2 experienced investigator-assessed objective responses as defined by RECIST v1.1. Three of those patients experienced confirmed response and remained in response. One new first response is subject to confirmation.</li>
<li>Seven of nine patients in Cohorts 1 and 2 remained free from disease progression after more than one year of follow-up</li>
<li>Perspective will hold a conference call on Monday, June 2, 2025 at 8:00 am ET &nbsp;</li>
</ul>

Biotech

CATX

Perspective Therapeutics Reveals New Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET At The 2025 ASCO Annual Meeting

LION

Liberty 77 Capital Reports 12.6% Stake In Lionsgate Studios As Of May 28 Vs Prior Stake Of 9.5% As Of May 6

CTXR

Citius Pharmaceuticals Not In Compliance With Nasdaq Minimum Bid Price

CoStar Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGP#NASDAQ">CSGP</a>), a leading provider of online real estate marketplaces, information, analytics and 3D digital twin technology in the property markets, announced today that CoStar Group and Happening Technology have concluded their dispute, with all parties withdrawing every claim with prejudice, bringing the matter to a final and amicable close.
Guy Wolcott, a serial entrepreneur, founded the successful residential real estate platform Homesnap in 2012, which CoStar Group acquired in 2020 for $250 million. At the time of the acquisition, Homesnap was used regularly by over 300,000 residential agents in the United States. After departing CoStar, Wolcott, Thomas Goff, and Jeff Repanich launched Happening Technology to develop an innovative data pipeline product, with former Homesnap CEO John Mazur later becoming an investor and board member. Similarities between this product and CoStar's internal data pipeline technology prompted CoStar's reasonable concern regarding potential trade secret misappropriation — concerns that have now been fully addressed. Following a thorough review, the parties concluded that neither Happening Technology nor Wolcott, Goff, Repanich, or Mazur misappropriated CoStar's trade secrets or violated any other legal obligation.
CoStar Group and Happening Technology are pleased to put this matter behind them and are open to exploring potential opportunities for collaboration in the future.

Legal

CSGP

CoStar Group And Happening Technology Resolve Trade Secret Dispute Amicably With All Claims Withdrawn; No Misappropriation Found As Parties Close Case And Express Openness To Future Collaboration

W.W. Grainger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) has outperformed the market over the past 20 years by 7.9% on an annualized basis producing an average annual return of 16.18%. Currently, W.W. Grainger has a market capitalization of $52.39 billion. 
Buying $100 In GWW: If an investor had bought $100 of GWW stock 20 years ago, it would be worth $2,014.00 today based on a price of $1087.60 for GWW at the time of writing.
<h3>W.W. Grainger's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748639712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In W.W. Grainger 20 Years Ago Would Be Worth Today

<h2 class="wp-block-heading">Zinger Points:</h2>
<ul class="wp-block-list">
<li>Crusoe secures $11.6 billion to build OpenAI's massive 1.2 gigawatt Abilene, Texas data center, part of the $500 billion Project Stargate.</li>
<li>Oracle has signed a 15-year lease to anchor the Abilene data center.</li>
<li>Crusoe's evolution from gas-powered crypto rigs to liquid-cooled AI supercenters captures the arc of next-gen computing.</li>
</ul>
AI infrastructure startup Crusoe Energy Systems has secured $11.6 billion in funding commitments to build a massive data center in Abilene, Texas, designed to support OpenAI's expanding computing needs. The new funding round, backed by Blue Owl Capital's Real Assets platform and Primary Digital Infrastructure, brings total capital raised for the project to $15 billion, The <a href="https://www.wsj.com/tech/ai/openai-data-center-funding-microsoft-75e879b6">Wall Street Journal </a>reported.
<h2 class="wp-block-heading">Abilene: The Heart of OpenAI&#8217;s Infrastructure Expansion</h2>
According to <a href="https://crusoe.ai/newsroom/crusoe-expands-ai-data-center-campus-in-abilene-to-1-2-gigawatts/">Crusoe</a>, the facility marks a critical step in OpenAI's infrastructure strategy. Initially planned as a two-building campus, the project now spans eight buildings. It is expected to deliver 1.2 gigawatts of power capacity, making it one of the largest AI training hubs globally.
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
According to the company, construction began last June, with the first two buildings—totaling 200 megawatts—expected to be energized in the first half of this year. A second phase, launched in March, will add six more buildings and is expected to be completed by mid-2026.
<h2 class="wp-block-heading">Oracle Steps In as Microsoft's Footprint Shrinks</h2>
The expansion comes amid growing demand for compute capacity as OpenAI develops increasingly advanced artificial intelligence models. Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) has signed a 15-year lease to occupy a significant portion of the Abilene campus, according to the Journal.&nbsp;
While Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) remains OpenAI's largest investor and retains exclusive application programming interface licensing rights, its role in the Abilene project is limited to that of a technology partner, without direct equity involvement. OpenAI has increasingly sought to diversify its infrastructure partnerships, citing concerns over Microsoft's ability to scale fast enough to meet its compute needs, the Journal reported.
Meanwhile, JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has committed over $7 billion to the data center project, building on a previous $2.3 billion investment, according to <a href="https://www.theinformation.com/articles/jpmorgan-lend-7-billion-openai-data-center">The Information</a>.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Project Stargate: A $500B Vision For AI Infrastructure</h2>
The Abilene project is part of &#8220;Project Stargate,&#8221; a $500 billion global AI infrastructure initiative launched in January by OpenAI, Oracle, SoftBank, and United Arab Emirates-based MGX, <a href="https://www.forbes.com/sites/emilsayegh/2025/01/22/stargate-ai-project-the-500-billion-gamble-to-dominate-the-future/">Forbes</a> reported. The project aims to build a vast network of AI data centers over the next four years to support rapid model development and increase U.S. leadership in artificial intelligence.
According to <a href="https://crusoe.ai/newsroom/crusoe-blue-owl-capital-and-primary-digital-infrastructure-enter-joint-venture">Crusoe</a>, the buildings planned in Abilene are designed for industry-scale performance, with each capable of running up to 50,000 GB200 NVL72 chips from Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) on a unified network fabric.
<h2 class="wp-block-heading">Economic and Environmental Considerations</h2>
Beyond scale, the Abilene campus is also a model for energy-conscious AI infrastructure. It incorporates direct-to-chip liquid cooling to manage thermal loads and partners with Lancium's Clean Campus program to integrate renewable energy sources, <a href="https://crusoe.ai/newsroom/crusoe-expands-ai-data-center-campus-in-abilene-to-1-2-gigawatts/">Crusoe</a> said. Crusoe expects the project to create over 5,000 jobs and generate more than $1 billion in local economic impact over the next two decades.
See Also: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">Crusoe's Strategic Shift</h2>
Founded in 2018, Denver-based Crusoe began as a company converting stranded natural gas into energy for crypto mining. In recent years, it has repositioned itself as a vertically integrated AI infrastructure provider, with a sharp focus on sustainable, high-density compute environments, according to <a href="https://news.crunchbase.com/ai/startup-crusoe-financing-openai-data-center-texas/">Crunchbase</a>.
The <a href="https://www.benzinga.com/24/12/42476730/peter-thiels-founders-fund-leads-600m-crusoe-investment-betting-big-on-ai-infrastructure">company raised $600 million</a> in Series D funding led by Founders Fund, with participation from Fidelity and Nvidia, bringing its valuation to $2.8 billion. The Abilene project represents Crusoe's most ambitious venture to date and positions it at the center of the rapidly expanding AI infrastructure race.
Read Next: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a>
Image: Shutterstock

Personal Finance

MSFT

NVDA

ORCL

OpenAI Secures $11.6B For Texas Data Center Expansion, Reducing Microsoft Dependence

A recent Reddit post from a frustrated husband in the r/Dave Ramsey <a href="https://www.reddit.com/r/DaveRamsey/comments/1kt761y/can_someone_confirm_my_wifes_spending_is/">subreddit</a> caught people&#8217;s attention after asking if his wife's spending habits were out of line. His main complaint? Over the last 90 days, the family spent $6,769 on dining out alone.
&#8220;Luckily we are positive net worth,&#8221; he wrote. &#8220;But she is delaying our retirement saying her spending is normal for having 2 kids. I cover probably 80-90% of essentials from my side.&#8221;
According to his breakdown, they also spent $1,330 on groceries during the same period, along with $1,230 on supplies, $1,250 on healthcare, $560 on gas, and $1,200 on other expenses.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Reddit Reacts: &#8216;That&#8217;s Almost $30K a Year&#8217;</h2>
The response was swift and nearly unanimous. One commenter was particularly direct: &#8220;Dining out isn't just delusional, <a href="https://www.benzinga.com/personal-finance/25/02/43602320/70-year-old-with-0-saved-for-retirement-still-works-physically-demanding-job-dave-ramsey-says-eating-out-is-causing-you-to-clean-toilets">it's irresponsible</a> and incredibly selfish. That's almost $30k a year.&#8221; They also pointed out that if they placed that money with a financial advisor, &#8220;at $2k a month, and they earned an average of 12%, you have almost $650k in 15 years.&#8221;
Another person added their own math of how much they could get over 30 years if they invested that money: &#8220;$6769 was for 3 months, so $27k/year. Turns into $3 mil in 30 years at 8%.&#8221;
Others were comparing themselves: &#8220;We make $380k a year and eat out about $500/month. That dining out number is terrifying.&#8221;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
<h2 class="wp-block-heading">&#8216;Stop Saying &#8220;I Cover Most of the Bills&#8221;&#8216;</h2>
While many were focused on the spending itself, others pushed the husband to reconsider how he approached the issue.
&#8220;Stop saying ‘I cover most of the bills&#8230;' you are we,&#8221; one person said, pointing to the importance of shared financial responsibility in a marriage, something Dave Ramsey often <a href="https://www.benzinga.com/personal-finance/25/02/43768530/should-married-couples-split-expenses-dave-ramsey-says-no-youre-married-not-roommates">teaches and preaches</a>.
Another chimed in with, &#8220;This reads more like a marriage issue than a money issue. Does she handle all of the child rearing and housework? Get off the spreadsheet and be the partner your wife needs and communicate through this issue.&#8221;
Still, others called for practical changes instead of blame. &#8220;Cut dining out to a quarter of that and add 1-2 grand to groceries and cook more – problem solved.&#8221;
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
<h2 class="wp-block-heading">Context Matters</h2>
Many asked for more context, like income and lifestyle. Some speculated that the high numbers may be inflated by convenience apps like DoorDash. The original poster later clarified that his wife eats out &#8220;2x a day at nice restaurants always with extra appetiser or entree with some meal for kids.&#8221;
Another commenter couldn't believe it: &#8220;That is not normal. Eating out is luxury, a treat. Eating out twice a day is not normal. She is choosing eating out over your future.&#8221;
Others shared how they made it work. &#8220;We make $240k a year and it was our New Year's resolution to eat out once a month,&#8221; one user wrote. &#8220;We spend maybe $100/month eating out and that&#8217;s because we&#8217;re trying.&#8221;
In the end, what this comes down to is that the spending problem the poster has isn't just about dollars and cents. &#8220;Delusional is not a word to use if you want to have a happy marriage,&#8221; one person advised. &#8220;Some work to be done on spending and discussing spending.&#8221;
Read Next:
<ul class="wp-block-list">
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

A Husband Asks, 'Can Someone Confirm My Wife's Spending Is Delusional?' He Points To $6,769 Spent On Dining Out In Just 90 Days

Management

RETO

On May 25, ReTo Eco-Solutions Hengfang Li Tendered Resignation As CEO And Director; Co. Appointed Xinyang Li To Serve As CEO

Asset Sales

APLD

Applied Digital Discussing Possible Sale Of Cloud Services Business; Cloud Services Business To Be Reported As Discontinued Operations

BBLG

Bone Biologics Approves Plan Amendment To Increase Shares By 30M

Offerings

ADAG

Adagene Files For Offering Of Up To $100M American Depositary Shares Representing Ordinary Shares

SharpLink Gaming Announces Private Placement Offering Of ~58.7M Shares Of Common Stock And Pre-Funded Warrants At $6.15 Per Share; CEO and CFO Participate With $200K Combined Investment

<h3>Gainers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock increased by 6.8% to $0.48 during Friday's after-market session. The company's market cap stands at $9.6 million. </li>
<li>Venu Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VENU#AMEX">VENU</a>) shares moved upwards by 6.55% to $9.98. The market value of their outstanding shares is at $378.3 million. </li>
<li>FAT Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATBP#NASDAQ">FATBP</a>) stock rose 5.8% to $2.37. </li>
<li>GEN Restaurant Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GENK#NASDAQ">GENK</a>) shares moved upwards by 4.84% to $3.46. The market value of their outstanding shares is at $17.4 million. </li>
<li>Fossil Group, Inc. - 7% Senior Notes due 2026 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOSLL#NASDAQ">FOSLL</a>) stock increased by 4.59% to $16.61. </li>
<li>Fly-E Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYE#NASDAQ">FLYE</a>) stock increased by 4.38% to $0.51. The market value of their outstanding shares is at $12.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>ContextLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGC#NASDAQ">LOGC</a>) stock decreased by 17.3% to $6.78 during Friday's after-market session. The market value of their outstanding shares is at $180.9 million. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) shares declined by 8.67% to $4.11. The company's market cap stands at $836.6 million. </li>
<li>Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) shares declined by 7.7% to $1.32. The market value of their outstanding shares is at $39.8 million. </li>
<li>Amesite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMST#NASDAQ">AMST</a>) shares declined by 5.5% to $2.75. The company's market cap stands at $12.5 million. </li>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) shares decreased by 4.84% to $73.0. The company's market cap stands at $50.9 million. </li>
<li>High Roller Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ROLR#AMEX">ROLR</a>) stock fell 4.82% to $4.15. The market value of their outstanding shares is at $34.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AMST

FATBP

FLYE

Fossil Group, Inc. - 7% Senior Notes due 2026

FOSLL

FTEL

GENK

LOGC

LVWR

ROLR

TLYS

VENU

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares rose 32.5% to $0.38 during Friday's after-market session. The market value of their outstanding shares is at $2.2 million. As per the press release, Q1 earnings came out today. </li>
<li>Kymera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KYMR#NASDAQ">KYMR</a>) shares rose 15.99% to $34.38. The market value of their outstanding shares is at $2.2 billion. </li>
<li>Liquidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LQDA#NASDAQ">LQDA</a>) stock moved upwards by 10.52% to $16.49. The company's market cap stands at $1.4 billion. </li>
<li>Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) shares moved upwards by 10.16% to $0.66. The market value of their outstanding shares is at $106.8 million. </li>
<li>Rafael Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RFL#NYSE">RFL</a>) stock rose 8.38% to $1.55. The market value of their outstanding shares is at $57.7 million. </li>
<li>Biote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTMD#NASDAQ">BTMD</a>) shares increased by 8.37% to $3.75. The market value of their outstanding shares is at $118.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LogicMark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) stock declined by 29.6% to $0.01 during Friday's after-market session. The market value of their outstanding shares is at $4.6 million. </li>
<li>Reshape Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) stock fell 15.69% to $4.14. The market value of their outstanding shares is at $3.0 million. </li>
<li>Entero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENTO#NASDAQ">ENTO</a>) shares decreased by 11.63% to $0.38. The market value of their outstanding shares is at $1.8 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) shares fell 10.53% to $5.44. The market value of their outstanding shares is at $102.1 million. </li>
<li>Silexion Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLXN#NASDAQ">SLXN</a>) shares declined by 8.74% to $0.94. The company's market cap stands at $8.1 million. </li>
<li>Intensity Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTS#NASDAQ">INTS</a>) shares decreased by 8.44% to $0.44. The market value of their outstanding shares is at $8.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BMGL

BTMD

ENTO

INTS

IRWD

KYMR

LGMK

LQDA

PSTV

RSLS

SLXN

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>JFB Construction (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFB#NASDAQ">JFB</a>) shares rose 17.0% to $6.55 during Friday's after-market session. The market value of their outstanding shares is at $60.5 million. </li>
<li>Energy Vault Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRGV#NYSE">NRGV</a>) shares moved upwards by 6.53% to $0.88. The market value of their outstanding shares is at $137.3 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares moved upwards by 5.44% to $0.32. The company's market cap stands at $8.4 million. </li>
<li>OneConstruction Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONEG#NASDAQ">ONEG</a>) shares rose 5.12% to $3.49. The market value of their outstanding shares is at $45.3 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares moved upwards by 5.0% to $0.49. The company's market cap stands at $15.4 million. </li>
<li>TrueBlue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TBI#NYSE">TBI</a>) shares increased by 4.99% to $6.3. The company's market cap stands at $187.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) stock decreased by 8.4% to $1.64 during Friday's after-market session. The market value of their outstanding shares is at $84.1 million. </li>
<li>OFA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFAL#NASDAQ">OFAL</a>) shares declined by 7.65% to $4.71. The market value of their outstanding shares is at $62.9 million. </li>
<li>Intelligent Living (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILAG#NASDAQ">ILAG</a>) stock declined by 6.16% to $0.37. The company's market cap stands at $6.6 million. </li>
<li>Eve Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVEX#NYSE">EVEX</a>) shares decreased by 5.56% to $5.1. The company's market cap stands at $1.5 billion. </li>
<li>Solidion Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares decreased by 5.17% to $3.12. The company's market cap stands at $8.4 million. </li>
<li>NET Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPWR#NYSE">NPWR</a>) shares decreased by 5.17% to $2.02. The market value of their outstanding shares is at $157.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EVEX

HTOO

ILAG

NPWR

NRGV

OFAL

ONEG

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) stock rose 77.2% to $0.49 during Friday's after-market session. The market value of their outstanding shares is at $20.4 million. </li>
<li>Infobird Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IFBD#NASDAQ">IFBD</a>) shares increased by 11.76% to $1.14. The market value of their outstanding shares is at $9.3 million. </li>
<li>Mobix Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOBX#NASDAQ">MOBX</a>) shares increased by 5.0% to $0.67. The company's market cap stands at $35.9 million. </li>
<li>Thumzup Media (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>) stock moved upwards by 4.98% to $8.63. The company's market cap stands at $82.0 million. </li>
<li>WM Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAPS#NASDAQ">MAPS</a>) stock moved upwards by 4.78% to $1.09. The market value of their outstanding shares is at $114.4 million. </li>
<li>Maris Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEK#NASDAQ">MTEK</a>) shares rose 4.62% to $2.26. The company's market cap stands at $17.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) stock declined by 9.2% to $1.09 during Friday's after-market session. The market value of their outstanding shares is at $79.0 million. </li>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock fell 4.49% to $2.98. The market value of their outstanding shares is at $4.5 million. </li>
<li>Actelis Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASNS#NASDAQ">ASNS</a>) stock fell 4.42% to $0.65. The market value of their outstanding shares is at $5.8 million. </li>
<li>BIO-key International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) stock fell 3.58% to $0.81. The company's market cap stands at $4.7 million. </li>
<li>Interlink Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINK#NASDAQ">LINK</a>) shares declined by 3.26% to $6.25. The market value of their outstanding shares is at $61.6 million. </li>
<li>Peraso (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRSO#NASDAQ">PRSO</a>) stock decreased by 3.01% to $0.91. The market value of their outstanding shares is at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASNS

BKYI

BNAI

GRYP

IFBD

LINK

MAPS

MOBX

MTEK

PRSO

SOBR

TZUP

12 Information Technology Stocks Moving In Friday's After-Market Session

OAKU

Oak Woods Acquisition Receives Nasdaq Deficiency Letter Regarding Delayed Filing of Quarterly Report on Form 10-Q

Financing

Press Releases

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

Health Care

Analyst Ratings

Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease

Earnings

Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights

Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference

Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones

Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference

Alumis

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Arvinas

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

GH Research

Harrow

LENZ Therapeutics

MBX Biosciences

Nuvation Bio

Septerna

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Tilray Brands

Trevi Therapeutics

Wave Life Sciences Ltd. - Ordinary Shares

WAVE Life Sciences

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings

Zevra Therapeutics

Zhengye Biotechnology Holding Limited - Ordinary Shares

Zhengye Biotechnology

Guggenheim

Leerink Partners

JP Morgan

米国の小売業者ファイブ・ビロウ(Five Below）（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>）の株は、市場予想を上回る四半期決算を発表し、第1四半期の<a href="https://in.benzinga.com/news/earnings/25/03/44406668/five-below-stock-moves-higher-on-q4-earnings-beat">見通し予想</a>を上回ることを受け、市場取引開始前の取引で株価が急上昇した。
ファイブ・ビロウは1株あたり3.48ドルの修正利益を報告した。これは市場予想（1株あたり3.38ドル）を上回っている。同社の売上は13億9100万ドルに対し、市場予想は13億8600万ドルだった。
ファイブ・ビロウの株は、プレマーケット取引で11.9％上昇して84.59ドルに急騰した。
以下は、プレマーケット取引で変動率が大きい銘柄である。
<h3 class="wp-block-heading">上昇銘柄</h3>
<ul>
<li>SAGホールディングス(SAG Holdings Limited)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAG#NASDAQ">SAG</a>）の株は、水曜日に7％上昇した後、プレマーケット取引で77.8％増の1.20ドルに急騰。</li>
<li>オプティノーズ(OptiNose, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTN#NASDAQ">OPTN</a>）の株は、プレマーケット取引で59.3％上昇の9.56ドルに上昇。パラテック・ファーマシューティカルズ(Paratek Pharmaceuticals)は、最大3.3億ドルでオプティノーズを買収する計画を発表。</li>
<li>プロアシュアランス(ProAssurance Corporation)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>）の株は、1株25.00ドルの現金で株式を買い取ることを発表した後、プレマーケット取引で50.6％急騰の23.41ドルに上昇。</li>
<li>AGMグループホールディングス(AGM Group Holdings Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGMH#NASDAQ">AGMH</a>）は、プレマーケットで0.1010ドル（約11.1円）に40.3％上昇。AGMグループホールディングスは、米国証券取引所（ナスダック）から最低入札要件に関する通知を受け取ったと発表。</li>
<li>DevvStream Corp（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>）の株は、水曜日に8％上昇した後、プレマーケット取引で28.7％上昇の0.4761ドルに急騰。</li>
<li>エマーソン・ラジオ(Emerson Radio Corp)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSN#NYSE">MSN</a>）は、プレマーケット取引で27.2％上昇の0.56ドル。</li>
<li>CIMG Inc（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IMG#NYSE">IMG</a>）の株は、同社の子会社がShanghai Huomaoとビジネス協力意向書に署名したと発表したことを受け、プレマーケット取引で21.1％上昇の0.5812ドルに急騰。</li>
<li>IOバイオテック(IO Biotech, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOBT#NASDAQ">IOBT</a>）の株は、プレマーケット取引で12.1％上昇の1.02ドルに上昇。</li>
<li>ブルックデール・シニア・リビング（Brookdale Senior Living Inc)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>）の株は、プレマーケット取引で8.1％上昇の6.60ドルに上昇。</li>
</ul>
<h3 class="wp-block-heading">下落銘柄</h3>
<ul>
<li>ズームカー・ホールディングス(Zoomcar Holdings, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>）の株は、逆株式分割1対20を発表した後、プレマーケット取引で28.4％急落の0.2196ドル。</li>
<li>アケビア・セラピューティクス(Akebia Therapeutics, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>）の株は、1株当たり2ドルで公開株式の2,500万株を5000万ドルで売却すると発表した後、プレマーケット取引で26.2％下落の2.09ドル。</li>
<li>レイシェン・エナジー・ホールディング（Leishen Energy Holding Co., Ltd）（NYSE:<a class="ticker" style="font-weight: revert;" href="https://www.benzinga.com/stock/LSE#NYSE">LSE</a>）の株は、水曜日に約66％上昇した後、プレマーケット取引で17.1％下落の10.37ドルに急落。最近、2024年度の業績報告を発表したばかり。</li>
<li>リバービュー・バンコープ(Riverview Bancorp, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVSB#NASDAQ">RVSB</a>）の株は、プレマーケット取引で13.2％急落の4.66ドル。</li>
<li>ベンソン・ヒル(Benson Hill, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NASDAQ">BHIL</a>）は、水曜日に15％下落した後、プレマーケット取引で13.2％急落の0.56ドルに下落。</li>
<li>バーパックス・ファーマシューティカルズ(Virpax Pharmaceuticals, Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>）の株は、逆株式分割1対25を発表した後、プレマーケット取引で13.2％急落の0.0944ドル。同社が逆株式分割を発表した水曜日に16％下落。</li>
<li>メイホワ・インタナショナル・メディカル・テクノロジズ（Meihua International Medical Technologies Co., Ltd）（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MHUA#NASDAQ">MHUA</a>）の株は、プレマーケット取引で12.3％下落の0.2884ドル。</li>
<li>本日のプレマーケット取引でMaze Therapeutics, Inc（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>）の株は11.8％下落し、10.70ドル。</li>
<li>ジョイ(JOYY Inc)（NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YY#NASDAQ">YY</a>）の株は、今日のプレマーケット取引で10.8％下落の41.78ドル。同社の四半期決算が弱かったことを受けての下落。</li>
<li>エナーフレックス(Enerflex Ltd)（NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFXT#NYSE">EFXT</a>）の株は、代表、CEO、取締役でもあるマーク・ロシター氏の辞任発表により、プレマーケット取引で7.1％下落の7.00ドル。</li>
</ul>
次の記事を読む：
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44396642/jim-cramer-says-tjx-is-terrific-recommends-buying-these-stocks">Jim Cramer氏はTJXが「素晴らしい」と述べ、これらの銘柄の購入をお勧め</a></li>
</ul>

Comments

Maze Therapeutics

ニュース

最新ニュース Maze Therapeutics (NASDAQ:MAZE) 株価情報

木曜日, 3 20, 2025

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル